Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment

BACKGROUND: In patients with amyloid-positive mild cognitive impairment (MCI), neurodegenerative biomarkers such as medial temporal lobe atrophy (MTA) are useful to predict disease progression to dementia. Although posterior atrophy (PA) is a well-known neurodegenerative biomarker of Alzheimer’s dis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Res Ther
Autors principals: Pyun, Jung-Min, Park, Young Ho, Kim, Hang-Rai, Suh, Jeewon, Kang, Min Ju, Kim, Beom Joon, Youn, Young Chul, Jang, Jae-Won, Kim, SangYun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732486/
https://ncbi.nlm.nih.gov/pubmed/29246250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0326-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars